Beovu (brolucizumab)

pCPA File Number: 21223
Negotiation Status:
Concluded with an LOI
Indication(s):
Age-Related Macular Degeneration
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
SR0632-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: